Meir Bialer - Search Results

Year	Number of Results
2002	4
2003	11
2004	11
2005	10
2006	7
2007	11
2008	5
2009	8
2010	7
2011	7
2012	13
2013	11
2014	4
2015	6
2016	4
2017	7
2018	3
2019	5
2020	8
2021	4
2022	5
2023	0

1

Fenfluramine repurposing from weight loss to epilepsy: What we do and do not know.

Odi R, Invernizzi RW, Gallily T, Bialer M, Perucca E. Odi R, et al. Among authors: bialer m. Pharmacol Ther. 2021 Oct;226:107866. doi: 10.1016/j.pharmthera.2021.107866. Epub 2021 Apr 22. Pharmacol Ther. 2021. PMID: 33895186 Review.

2

Cannabidiol in the treatment of epilepsy: Current evidence and perspectives for further research.

Franco V, Bialer M, Perucca E. Franco V, et al. Among authors: bialer m. Neuropharmacology. 2021 Mar 1;185:108442. doi: 10.1016/j.neuropharm.2020.108442. Epub 2021 Jan 12. Neuropharmacology. 2021. PMID: 33347884 Review.

3

The Interplay Between Liver First-Pass Effect and Lymphatic Absorption of Cannabidiol and Its Implications for Cannabidiol Oral Formulations.

Franco V, Gershkovich P, Perucca E, Bialer M. Franco V, et al. Among authors: bialer m. Clin Pharmacokinet. 2020 Dec;59(12):1493-1500. doi: 10.1007/s40262-020-00931-w. Clin Pharmacokinet. 2020. PMID: 32785853

4

Valproic Acid: second generation.

Bialer M, Yagen B. Bialer M, et al. Neurotherapeutics. 2007 Jan;4(1):130-7. doi: 10.1016/j.nurt.2006.11.007. Neurotherapeutics. 2007. PMID: 17199028 Free PMC article. Review.

5

Lorcaserin for Dravet Syndrome: A Potential Advance Over Fenfluramine?

Bialer M, Perucca E. Bialer M, et al. CNS Drugs. 2022 Feb;36(2):113-122. doi: 10.1007/s40263-022-00896-3. Epub 2022 Jan 30. CNS Drugs. 2022. PMID: 35094259 Review.

6

Pharmacokinetic interactions of topiramate.

Bialer M, Doose DR, Murthy B, Curtin C, Wang SS, Twyman RE, Schwabe S. Bialer M, et al. Clin Pharmacokinet. 2004;43(12):763-80. doi: 10.2165/00003088-200443120-00001. Clin Pharmacokinet. 2004. PMID: 15355124 Review.

7

Novel treatment approaches and pediatric research networks in status epilepticus.

Bialer M, Cross H, Hedrich UBS, Lagae L, Lerche H, Loddenkemper T. Bialer M, et al. Epilepsy Behav. 2019 Dec;101(Pt B):106564. doi: 10.1016/j.yebeh.2019.106564. Epub 2019 Nov 8. Epilepsy Behav. 2019. PMID: 31708430 Review.

8

Chemical properties of antiepileptic drugs (AEDs).

Bialer M. Bialer M. Adv Drug Deliv Rev. 2012 Jul;64(10):887-95. doi: 10.1016/j.addr.2011.11.006. Epub 2011 Nov 21. Adv Drug Deliv Rev. 2012. PMID: 22210279 Review.

9

A summary of data presented at the XIV conference on new antiepileptic drug and devices (EILAT XIV).

Bialer M, Johannessen SI, Koepp MJ, Levy RH, Perucca E, Tomson T, White HS. Bialer M, et al. Epilepsy Res. 2019 Jul;153:66-67. doi: 10.1016/j.eplepsyres.2019.03.002. Epub 2019 Mar 11. Epilepsy Res. 2019. PMID: 30910314

10

Why are antiepileptic drugs used for nonepileptic conditions?

Bialer M. Bialer M. Epilepsia. 2012 Dec;53 Suppl 7:26-33. doi: 10.1111/j.1528-1167.2012.03712.x. Epilepsia. 2012. PMID: 23153207 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results